ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Amyotrophic Lateral Sclerosis Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-12C6142
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Amyotrophic Lateral Sclerosis Drugs Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Amyotrophic Lateral Sclerosis Drugs Market Research Report 2025

Code: QYRE-Auto-12C6142
Report
September 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Mitsubishi Tanabe Pharma
Mylan NV
Apotex
Glemark Generics
Sun Pharma
Covis Pharma
Lunan Pharma
CSPC Pharmaceutical
Ascend Laboratories
Eisai Co Ltd

Amyotrophic Lateral Sclerosis Drugs Market Size

The global market for Amyotrophic Lateral Sclerosis Drugs was valued at US$ 314 million in the year 2024 and is projected to reach a revised size of US$ 368 million by 2031, growing at a CAGR of 2.3% during the forecast period.

Amyotrophic Lateral Sclerosis Drugs Market

Amyotrophic Lateral Sclerosis Drugs Market

Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.
The cause is not known in 90% to 95% of cases. The remaining 5–10% of cases are inherited from a person"s parents. About half of these genetic cases are due to one of two specific genes. The underlying mechanism involves damage to both upper and lower motor neurons. The diagnosis is based on a person"s signs and symptoms, with testing done to rule out other potential causes.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Amyotrophic Lateral Sclerosis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amyotrophic Lateral Sclerosis Drugs.
The Amyotrophic Lateral Sclerosis Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amyotrophic Lateral Sclerosis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amyotrophic Lateral Sclerosis Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Amyotrophic Lateral Sclerosis Drugs Market Report

Report Metric Details
Report Name Amyotrophic Lateral Sclerosis Drugs Market
Accounted market size in year US$ 314 million
Forecasted market size in 2031 US$ 368 million
CAGR 2.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Riluzole
  • Edaravone (Radicava)
  • CoQ10
  • Butylphthalide
  • Others
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Mitsubishi Tanabe Pharma, Mylan, Apotex, Glemark Generics, Sun Pharma, Covis Pharma, Lunan Pharma, CSPC Pharmaceutical, Ascend Laboratories, EISAI
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Amyotrophic Lateral Sclerosis Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Amyotrophic Lateral Sclerosis Drugs Market growing?

Ans: The Amyotrophic Lateral Sclerosis Drugs Market witnessing a CAGR of 2.3% during the forecast period 2025-2031.

What is the Amyotrophic Lateral Sclerosis Drugs Market size in 2031?

Ans: The Amyotrophic Lateral Sclerosis Drugs Market size in 2031 will be US$ 368 million.

Who are the main players in the Amyotrophic Lateral Sclerosis Drugs Market report?

Ans: The main players in the Amyotrophic Lateral Sclerosis Drugs Market are Sanofi, Mitsubishi Tanabe Pharma, Mylan, Apotex, Glemark Generics, Sun Pharma, Covis Pharma, Lunan Pharma, CSPC Pharmaceutical, Ascend Laboratories, EISAI

What are the Application segmentation covered in the Amyotrophic Lateral Sclerosis Drugs Market report?

Ans: The Applications covered in the Amyotrophic Lateral Sclerosis Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Amyotrophic Lateral Sclerosis Drugs Market report?

Ans: The Types covered in the Amyotrophic Lateral Sclerosis Drugs Market report are Riluzole, Edaravone (Radicava), CoQ10, Butylphthalide, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Riluzole
1.2.3 Edaravone (Radicava)
1.2.4 CoQ10
1.2.5 Butylphthalide
1.2.6 Others
1.3 Market by Application
1.3.1 Global Amyotrophic Lateral Sclerosis Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Perspective (2020-2031)
2.2 Global Amyotrophic Lateral Sclerosis Drugs Growth Trends by Region
2.2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Region (2020-2025)
2.2.3 Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Region (2026-2031)
2.3 Amyotrophic Lateral Sclerosis Drugs Market Dynamics
2.3.1 Amyotrophic Lateral Sclerosis Drugs Industry Trends
2.3.2 Amyotrophic Lateral Sclerosis Drugs Market Drivers
2.3.3 Amyotrophic Lateral Sclerosis Drugs Market Challenges
2.3.4 Amyotrophic Lateral Sclerosis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Amyotrophic Lateral Sclerosis Drugs Players by Revenue
3.1.1 Global Top Amyotrophic Lateral Sclerosis Drugs Players by Revenue (2020-2025)
3.1.2 Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Amyotrophic Lateral Sclerosis Drugs Revenue
3.4 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio
3.4.1 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Drugs Revenue in 2024
3.5 Global Key Players of Amyotrophic Lateral Sclerosis Drugs Head office and Area Served
3.6 Global Key Players of Amyotrophic Lateral Sclerosis Drugs, Product and Application
3.7 Global Key Players of Amyotrophic Lateral Sclerosis Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Amyotrophic Lateral Sclerosis Drugs Breakdown Data by Type
4.1 Global Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Type (2020-2025)
4.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Type (2026-2031)
5 Amyotrophic Lateral Sclerosis Drugs Breakdown Data by Application
5.1 Global Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Application (2020-2025)
5.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size (2020-2031)
6.2 North America Amyotrophic Lateral Sclerosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2020-2025)
6.4 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size (2020-2031)
7.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2020-2025)
7.4 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size (2020-2031)
8.2 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size (2020-2031)
9.2 Latin America Amyotrophic Lateral Sclerosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2020-2025)
9.4 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size (2020-2031)
10.2 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Amyotrophic Lateral Sclerosis Drugs Introduction
11.1.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 Mitsubishi Tanabe Pharma
11.2.1 Mitsubishi Tanabe Pharma Company Details
11.2.2 Mitsubishi Tanabe Pharma Business Overview
11.2.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.2.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
11.2.5 Mitsubishi Tanabe Pharma Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Amyotrophic Lateral Sclerosis Drugs Introduction
11.3.4 Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
11.3.5 Mylan Recent Development
11.4 Apotex
11.4.1 Apotex Company Details
11.4.2 Apotex Business Overview
11.4.3 Apotex Amyotrophic Lateral Sclerosis Drugs Introduction
11.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
11.4.5 Apotex Recent Development
11.5 Glemark Generics
11.5.1 Glemark Generics Company Details
11.5.2 Glemark Generics Business Overview
11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Introduction
11.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
11.5.5 Glemark Generics Recent Development
11.6 Sun Pharma
11.6.1 Sun Pharma Company Details
11.6.2 Sun Pharma Business Overview
11.6.3 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.6.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
11.6.5 Sun Pharma Recent Development
11.7 Covis Pharma
11.7.1 Covis Pharma Company Details
11.7.2 Covis Pharma Business Overview
11.7.3 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.7.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
11.7.5 Covis Pharma Recent Development
11.8 Lunan Pharma
11.8.1 Lunan Pharma Company Details
11.8.2 Lunan Pharma Business Overview
11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
11.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
11.8.5 Lunan Pharma Recent Development
11.9 CSPC Pharmaceutical
11.9.1 CSPC Pharmaceutical Company Details
11.9.2 CSPC Pharmaceutical Business Overview
11.9.3 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Introduction
11.9.4 CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
11.9.5 CSPC Pharmaceutical Recent Development
11.10 Ascend Laboratories
11.10.1 Ascend Laboratories Company Details
11.10.2 Ascend Laboratories Business Overview
11.10.3 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Introduction
11.10.4 Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
11.10.5 Ascend Laboratories Recent Development
11.11 EISAI
11.11.1 EISAI Company Details
11.11.2 EISAI Business Overview
11.11.3 EISAI Amyotrophic Lateral Sclerosis Drugs Introduction
11.11.4 EISAI Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
11.11.5 EISAI Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Sanofi
Mitsubishi Tanabe Pharma
Mylan NV
Apotex
Glemark Generics
Sun Pharma
Covis Pharma
Lunan Pharma
CSPC Pharmaceutical
Ascend Laboratories
Eisai Co Ltd
List of Tables
 Table 1. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Riluzole
 Table 3. Key Players of Edaravone (Radicava)
 Table 4. Key Players of CoQ10
 Table 5. Key Players of Butylphthalide
 Table 6. Key Players of Others
 Table 7. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Region (2020-2025)
 Table 11. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Region (2026-2031)
 Table 13. Amyotrophic Lateral Sclerosis Drugs Market Trends
 Table 14. Amyotrophic Lateral Sclerosis Drugs Market Drivers
 Table 15. Amyotrophic Lateral Sclerosis Drugs Market Challenges
 Table 16. Amyotrophic Lateral Sclerosis Drugs Market Restraints
 Table 17. Global Amyotrophic Lateral Sclerosis Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Players (2020-2025)
 Table 19. Global Top Amyotrophic Lateral Sclerosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Drugs as of 2024)
 Table 20. Ranking of Global Top Amyotrophic Lateral Sclerosis Drugs Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Amyotrophic Lateral Sclerosis Drugs, Headquarters and Area Served
 Table 23. Global Key Players of Amyotrophic Lateral Sclerosis Drugs, Product and Application
 Table 24. Global Key Players of Amyotrophic Lateral Sclerosis Drugs, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2020-2025)
 Table 28. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2026-2031)
 Table 30. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Application (2020-2025)
 Table 32. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Application (2026-2031)
 Table 34. North America Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Sanofi Company Details
 Table 50. Sanofi Business Overview
 Table 51. Sanofi Amyotrophic Lateral Sclerosis Drugs Product
 Table 52. Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025) & (US$ Million)
 Table 53. Sanofi Recent Development
 Table 54. Mitsubishi Tanabe Pharma Company Details
 Table 55. Mitsubishi Tanabe Pharma Business Overview
 Table 56. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product
 Table 57. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025) & (US$ Million)
 Table 58. Mitsubishi Tanabe Pharma Recent Development
 Table 59. Mylan Company Details
 Table 60. Mylan Business Overview
 Table 61. Mylan Amyotrophic Lateral Sclerosis Drugs Product
 Table 62. Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025) & (US$ Million)
 Table 63. Mylan Recent Development
 Table 64. Apotex Company Details
 Table 65. Apotex Business Overview
 Table 66. Apotex Amyotrophic Lateral Sclerosis Drugs Product
 Table 67. Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025) & (US$ Million)
 Table 68. Apotex Recent Development
 Table 69. Glemark Generics Company Details
 Table 70. Glemark Generics Business Overview
 Table 71. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product
 Table 72. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025) & (US$ Million)
 Table 73. Glemark Generics Recent Development
 Table 74. Sun Pharma Company Details
 Table 75. Sun Pharma Business Overview
 Table 76. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product
 Table 77. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025) & (US$ Million)
 Table 78. Sun Pharma Recent Development
 Table 79. Covis Pharma Company Details
 Table 80. Covis Pharma Business Overview
 Table 81. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product
 Table 82. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025) & (US$ Million)
 Table 83. Covis Pharma Recent Development
 Table 84. Lunan Pharma Company Details
 Table 85. Lunan Pharma Business Overview
 Table 86. Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Product
 Table 87. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025) & (US$ Million)
 Table 88. Lunan Pharma Recent Development
 Table 89. CSPC Pharmaceutical Company Details
 Table 90. CSPC Pharmaceutical Business Overview
 Table 91. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product
 Table 92. CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025) & (US$ Million)
 Table 93. CSPC Pharmaceutical Recent Development
 Table 94. Ascend Laboratories Company Details
 Table 95. Ascend Laboratories Business Overview
 Table 96. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product
 Table 97. Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025) & (US$ Million)
 Table 98. Ascend Laboratories Recent Development
 Table 99. EISAI Company Details
 Table 100. EISAI Business Overview
 Table 101. EISAI Amyotrophic Lateral Sclerosis Drugs Product
 Table 102. EISAI Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025) & (US$ Million)
 Table 103. EISAI Recent Development
 Table 104. Research Programs/Design for This Report
 Table 105. Key Data Information from Secondary Sources
 Table 106. Key Data Information from Primary Sources
 Table 107. Authors List of This Report


List of Figures
 Figure 1. Amyotrophic Lateral Sclerosis Drugs Picture
 Figure 2. Global Amyotrophic Lateral Sclerosis Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Riluzole Features
 Figure 5. Edaravone (Radicava) Features
 Figure 6. CoQ10 Features
 Figure 7. Butylphthalide Features
 Figure 8. Others Features
 Figure 9. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Pharmacies Case Studies
 Figure 12. Retail Pharmacies Case Studies
 Figure 13. Online Pharmacies Case Studies
 Figure 14. Amyotrophic Lateral Sclerosis Drugs Report Years Considered
 Figure 15. Global Amyotrophic Lateral Sclerosis Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Amyotrophic Lateral Sclerosis Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Region: 2024 VS 2031
 Figure 18. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Players in 2024
 Figure 19. Global Top Amyotrophic Lateral Sclerosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amyotrophic Lateral Sclerosis Drugs as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Drugs Revenue in 2024
 Figure 21. North America Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2020-2031)
 Figure 23. United States Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2020-2031)
 Figure 27. Germany Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Share by Region (2020-2031)
 Figure 35. China Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2020-2031)
 Figure 43. Mexico Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2020-2031)
 Figure 47. Turkey Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
 Figure 51. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
 Figure 52. Mylan Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
 Figure 53. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
 Figure 54. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
 Figure 55. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
 Figure 56. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
 Figure 57. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
 Figure 58. CSPC Pharmaceutical Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
 Figure 59. Ascend Laboratories Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
 Figure 60. EISAI Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13Z8760
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Intracranial Pressure (ICP) Monitoring Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37L4006
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Brain Disease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12P6151
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3X6389
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions